For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Frequency Therapeutics, Inc.

USPTO Granted Patents = 14

% Expired Patents = 28.6

Trademarks = 4

Forward Citations = 27

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Christopher Loose (14 out of 14 patents)

Will Mclean (14 out of 14 patents)

Megan Harrison (8 out of 8 patents)

4. Michael R Jirousek (6 out of 37 patents)

5. Melissa Hill-Drzewi (5 out of 5 patents)

6. Bradley Tait (2 out of 19 patents)

7. Rajesh Manchanda (2 out of 2 patents)

14 patents: Sort by Forward Citations

1. 11617745 - Compositions and methods for generating hair cells by downregulating FOXO (2023-04-04),

2. 11260130 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV (2022-03-01),

3. 11162071 - Compositions and methods for generating hair cells by upregulating JAG-1 (2021-11-02),

4. 11160868 - Thermoreversible compositions for administration of therapeutic agents (2021-11-02),

5. 11066419 - 1H-pyrrole-2,5-dione compounds and methods of using same (2021-07-20),

6. 11033546 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: I (2021-06-15),

7. 10383881 - 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same (2019-08-20),

8. 10220041 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds (2019-03-05),

9. 10213511 - Thermoreversible compositions for administration of therapeutic agents (2019-02-26),

10. 10201540 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I (2019-02-12),

11. 10016507 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III (2018-07-10),

12. 9968615 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds (2018-05-15),

13. 9913848 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 1,2,3,4-tetrahydro-[1,4]diazepino[6,7, 1-hi]indolyl based compounds (2018-03-13),

14. 9913835 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using N-(alkylcarbamoyl)-1H-pyrazol-4-yl)-nicotinamide based compounds (2018-03-13),

Frequency Therapeutics is a clinical-stage biotechnology company pioneering the use of cell therapy to restore hearing function. Their proprietary Progenitor Cell Activation platform aims to activate the regenerative potential of the body's progenitor cells to treat a broad range of hearing disorders. By leveraging the innate ability of progenitor cells to regenerate damaged tissue, Frequency Therapeutics aims to develop novel therapies that address the root cause of hearing loss, providing new hope for patients.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Frequency Therapeutics, Inc.

14 Patents

#49 in Lexington, MA

#1,359 in Massachusetts

#22,289 in US

#42,168 in the World

Lexington, MA, United States of America

Frequency Therapeutics, Inc.

Forward Citations = 27

7 inventors:

Christopher Loose (14 out of 14 patents)

Will Mclean (14 out of 14 patents)

Megan Harrison (8 out of 8 patents)

4. Michael R Jirousek (6 out of 37 patents)

5. Melissa Hill-Drzewi (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…